ClinicalTrials.gg

Program

tafamidis

Also written as “Tafamidis”, “Fx-1006A” and “Tafamidis 61 mg free acid capsule (Reference)”.

Its studies are mostly in Amyloid Neuropathies, Familial · Cardiomyopathies · Amyloidosis, led by Pfizer.

Furthest: phase 4, since Mar 10, 202129 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Pfizer290 open or runningphase 4since Mar 10, 2021Dec 6, 2006none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 14 studies since Dec 6, 2006.

  1. Feb 29, 2016Phase 1 study in HealthyNCT02697864 · 12 enrolled · Belgium
  2. Apr 18, 2016Phase 1 study in HealthyNCT02746926 · 12 enrolled · United States
  3. Jun 1, 2016Phase 3 study in Amyloid Neuropathies, FamilialNCT02791230 · 1,733 enrolled · United States, Argentina, Australia and more
  4. Aug 28, 2017Phase 1 study in HealthyNCT03266705 · 30 enrolled · Belgium
  5. Sep 5, 2017Phase 1 study in HealthyNCT03280173 · 18 enrolled · Belgium
  6. Aug 23, 2018Phase 1 study in Healthy VolunteersNCT03662191 · 9 enrolled · Belgium
  7. Jan 31, 2020Phase 1 study in Healthy VolunteersNCT04253353 · 12 enrolled · Belgium
  8. Sep 23, 2020Phase 1 study in HealthyNCT04575116 · 23 enrolled · United States
  9. Mar 10, 20212 phase 4 studiesNCT04814186, NCT04828993
  10. Aug 10, 2022Phase 1 study in HealthyNCT05498701 · 22 enrolled · Canada
  11. Feb 15, 2024Phase 1 study in HealthyNCT06273839 · 12 enrolled · Belgium
  12. Nov 22, 2024Phase 1 study in HealthyNCT06705569 · 22 enrolled · Belgium
  13. Mar 10, 2026Phase 1 study in HealthyNCT07470866 · 24 enrolled · Belgium
  14. May 8, 2026Phase 1 study in Healthy AdultsNCT07587697 · 30 enrolled · Japan

TargetBeta

TTR →read by rule
“Transthyretin stabiliser; Transthyretin stabiliser”ChEMBL 37, by rule

Other programs on TTR

ProgramCompanyFurthest phaseStudies
acoramidisruleBridgeBiophase 415
coramitugNovo Nordiskphase 33
coramitugNovo Nordiskphase 12

Studies

All 29 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07587697Healthy Adults · Japan1CompletedAug 3, 202630
NCT07470866Healthy · Belgium1TerminatedMay 12, 202624
NCT06705569Healthy · Belgium1CompletedApr 4, 202522
NCT06273839Healthy · Belgium1CompletedMay 27, 202412
NCT05498701Healthy · Canada1CompletedDec 18, 202222
NCT04828993Amyloid Neuropathies, Familial · China4CompletedFeb 12, 202315
NCT04814186Transthyretin Amyloid Cardiomyopathy · China4CompletedOct 16, 202353
NCT04575116Healthy · United States1CompletedFeb 23, 202123
NCT04253353Healthy Volunteers · Belgium1CompletedAug 10, 202012
NCT03662191Healthy Volunteers · Belgium1CompletedJan 10, 20199
NCT03280173Healthy · Belgium1CompletedFeb 23, 201818
NCT03266705Healthy · Belgium1CompletedFeb 15, 201830
NCT02791230Amyloid Neuropathies, Familial · United States, Argentina, Australia and more3CompletedOct 26, 20231,733
NCT02746926Healthy · United States1CompletedJul 15, 201612
NCT02697864Healthy · Belgium1CompletedJun 201612
NCT02534740Healthy · Belgium1CompletedDec 201518
NCT02406560Healthy Volunteers · Belgium1CompletedJun 201512
NCT02217813Healthy Volunteers · Belgium1CompletedNov 201426
NCT02189330Healthy Volunteers · Belgium1CompletedJul 201424
NCT01994889Amyloid Neuropathies, Familial · United States, Belgium, Brazil and more3CompletedFeb 7, 2018441
NCT01655511TTR Cardiomyopathy · Singapore1CompletedSep 20129
NCT01435655Transthyretin Familial Amyloid Polyneuropathy · Japan3CompletedFeb 201410
NCT01358565Mild Hepatic Dysfunction · South Africa1CompletedApr 201116
NCT00935012Cardiomyopathies · United States3CompletedNov 20, 201931
NCT00925002ATTR-PN · United States, Argentina, Brazil and more3CompletedJul 8, 202093
NCT00791492Amyloid Neuropathies, Familial · Argentina, Brazil, France and more3CompletedAug 200886
NCT00694161Cardiomyopathies · United States2CompletedJan 201035
NCT00630864Amyloidosis · United States, France, Germany and more2CompletedJan 201021
NCT00409175Amyloid Neuropathies, Familial · United States, Argentina, Brazil and more3CompletedMay 2009128

How it is read

Names in the registry

  • “Tafamidis”, 19 entries
  • “tafamidis”, 13 entries
  • “Fx-1006A”, 6 entries
  • “Tafamidis 61 mg free acid capsule (Reference)”, 2 entries
  • “Tafamidis (Reference)”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.